WFG Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$193K Buy
793
+137
+21% +$32.2K 0.04% 376
2017
Q1
$157K Buy
656
+26
+4% +$6.05K 0.04% 385
2016
Q4
$132K Sell
630
-60
-9% -$12.4K 0.03% 463
2016
Q3
$159K Sell
690
-30
-4% -$7.33K 0.04% 419
2016
Q2
$166K Buy
720
+217
+43% +$50K 0.04% 385
2016
Q1
$135K Sell
503
-50
-9% -$14.3K 0.04% 415
2015
Q4
$173K Buy
553
+517
+1,436% +$154K 0.05% 324
2015
Q3
$10K Hold
36
﹤0.01% 1105
2015
Q2
$11K Sell
36
-5
-12% -$1.49K ﹤0.01% 1171
2015
Q1
$12K Buy
41
+37
+925% +$10.5K ﹤0.01% 1163
2014
Q4
$1K Hold
4
﹤0.01% 2022
2014
Q3
$1K Buy
+4
New +$895 ﹤0.01% 2037

Other funds holding AGN

WFG Advisors's AGN Position: Q2 2017 in Review

WFG Advisors increased its Allergan plc (AGN) stake by 21% in Q2 2017, buying an estimated $32.2K and bringing the position to 793 shares worth $193K. The position accounts for 0.04% of the portfolio, ranked #376.

WFG Advisors first reported a position in AGN in Q3 2014 and has held it in 12 quarters since. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • WFG Advisors held 793 shares of Allergan plc worth $193K as of Q2 2017.
  • WFG Advisors bought 137 Allergan plc shares in Q2 2017, an estimated $32.2K.
  • Allergan plc made up 0.04% of WFG Advisors's portfolio in Q2 2017, its #376 holding.
  • WFG Advisors first reported a position in Allergan plc in Q3 2014 and has held it in 12 quarters since.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.